Healthier Choices Management (HCMC) 10-Q 18 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 06, 2020
Cover [Abstract]
Entity Registrant Name	Healthier Choices Management Corp.
Entity Central Index Key	0000844856
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		105,110,848,016
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Address, State or Province	FL

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash and cash equivalents	$ 602,318	$ 1,525,415
Accounts receivable, net	85,527	65,401
Inventories	1,785,959	1,757,012
Prepaid expenses and vendor deposits	328,008	269,833
Investment	10,286	24,000
TOTAL CURRENT ASSETS	2,812,098	3,641,661
Restricted cash	4,386,081	2,000,000
Property and equipment, net of accumulated depreciation	258,774	332,290
Intangible assets, net of accumulated amortization	1,346,374	1,923,447
Goodwill	916,000	956,000
Note receivable	319,620	343,387
Right of use asset - operating lease, net	4,234,280	4,663,019
Other assets	89,595	146,865
TOTAL ASSETS	14,362,822	14,006,669
CURRENT LIABILITIES
Accounts payable and accrued expenses	1,090,831	825,860
Contract liabilities	19,400	26,823
Current portion of line of credit	2,000,000	2,000,000
Current portion of loan payment	3,392,466	282,344
Operating lease liability, current	502,289	555,959
TOTAL CURRENT LIABILITIES	7,004,986	3,690,986
Loan payable, net of current portion	965,675	869,223
Operating lease liability, net of current	3,225,215	3,544,729
TOTAL LIABILITIES	11,195,876	8,104,938
COMMITMENTS AND CONTINGENCIES (SEE NOTE 8)
STOCKHOLDERS' EQUITY
Series B convertible preferred stock, $1,000 par value per share, 30,000 shares authorized; 20,150 shares issued and outstanding as of September 30, 2020 and December 31, 2019; aggregate liquidation preference of $20.2 million	20,150,116	20,150,116
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; approximately 105.1 and 67.7 billion shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	10,511,085	6,769,849
Additional paid-in capital	3,953,163	7,618,245
Accumulated deficit	(31,447,418)	(28,636,479)
TOTAL STOCKHOLDERS' EQUITY	3,166,946	5,901,731
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 14,362,822	$ 14,006,669

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
STOCKHOLDERS' EQUITY
Series B convertible preferred stock, par value (in dollars per share)	$ 1,000	$ 1,000
Series B convertible preferred stock, shares authorized (in shares)	30,000	30,000
Series B convertible preferred stock, shares issued (in shares)	20,150	20,150
Series B convertible preferred stock, shares outstanding (in shares)	20,150	20,150
Series B convertible preferred stock, aggregate liquidation preference	$ 20.2	$ 20.2
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	750,000,000,000	750,000,000,000
Common stock, shares issued (in shares)	105,100,000,000	67,700,000,000
Common stock, shares outstanding (in shares)	105,100,000,000	67,700,000,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
SALES
TOTAL SALES, NET	$ 3,347,793	$ 3,418,330	$ 10,692,877	$ 11,615,449
GROSS PROFIT	1,362,119	1,403,142	4,443,305	4,968,327
Selling, general and administrative	2,195,275	2,532,505	6,735,815	8,057,452
Impairment of intangible assets	380,646	0	380,646	0
OPERATING EXPENSES	2,575,921	2,532,505	7,116,461	8,057,452
LOSS FROM OPERATIONS	(1,213,802)	(1,129,363)	(2,673,156)	(3,089,125)
OTHER (EXPENSE) INCOME
Gain (loss) on investment	(2,571)	(12,514)	(13,714)	(57,514)
Other expense, net	0	(146)	(100)	(838)
Interest income (expense), net	(84,592)	(8,280)	(123,969)	(19,669)
Total other (expense) income, net	(87,163)	(20,940)	(137,783)	(78,021)
NET LOSS	$ (1,300,965)	$ (1,150,303)	$ (2,810,939)	$ (3,167,146)
NET LOSS PER SHARE-BASIC AND DILUTED (in dollars per share)	$ 0	$ 0	$ 0	$ 0
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC AND DILUTED (in shares)	102,108,302,961	66,929,136,282	84,476,736,667	66,734,751,470
Vapor [Member]
SALES
TOTAL SALES, NET	$ 594,145	$ 898,229	$ 1,888,480	$ 3,207,530
Cost of sales	256,461	385,208	787,998	1,337,555
Grocery [Member]
SALES
TOTAL SALES, NET	2,753,648	2,520,101	8,804,397	8,407,919
Cost of sales	$ 1,729,213	$ 1,629,980	$ 5,461,574	$ 5,309,567

CONDENSED CONSOLIDATED STOCKHOL

CONDENSED CONSOLIDATED STOCKHOLDERS' EQUITY STATEMENTS (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Convertible Preferred Stock [Member]	Total	Cumulative Effect, Period of Adoption, Adjustment [Member]Accumulated Deficit [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2018	$ 6,662,351	$ 7,348,390	$ (25,734,088)	$ 20,150,116	$ 8,426,769
Balance (ASU 2016-02 [Member]) at Dec. 31, 2018						$ (103,015)	$ (103,015)
Balance (in shares) at Dec. 31, 2018	66,623,514,522			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 7,498	(4,386)			3,112
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	74,979,719
Issuance of awarded stock for board members	$ 100,000	(100,000)			0
Issuance of awarded stock for board members (in shares)	1,000,000,000
Stock-based compensation expense			343,824		343,824
Net loss			(3,167,146)		(3,167,146)
Balance at Sep. 30, 2019	$ 6,769,849	7,587,828	(29,004,249)	$ 20,150,116	5,503,544
Balance (in shares) at Sep. 30, 2019	67,698,494,241			20,150
Balance at Jun. 30, 2019	$ 6,664,526	7,543,370	(27,853,946)	$ 20,150,116	6,504,066
Balance (in shares) at Jun. 30, 2019	66,645,257,694			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 5,323	(3,112)			2,211
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	53,236,547
Issuance of awarded stock for board members	$ 100,000	(100,000)			0
Issuance of awarded stock for board members (in shares)	1,000,000,000
Stock-based compensation expense		147,570			147,570
Net loss			(1,150,303)		(1,150,303)
Balance at Sep. 30, 2019	$ 6,769,849	7,587,828	(29,004,249)	$ 20,150,116	5,503,544
Balance (in shares) at Sep. 30, 2019	67,698,494,241			20,150
Balance at Dec. 31, 2019	$ 6,769,849	7,618,245	(28,636,479)	$ 20,150,116	5,901,731
Balance (in shares) at Dec. 31, 2019	67,698,494,244			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 3,741,235	(3,741,235)			$ 0
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	37,412,353,772				37,412,353,771
Stock-based compensation expense		76,154			$ 76,154
Net loss			(2,810,939)		(2,810,939)
Balance at Sep. 30, 2020	$ 10,511,084	3,953,164	(31,447,418)	$ 20,150,116	3,166,946
Balance (in shares) at Sep. 30, 2020	105,110,848,016			20,150
Balance at Jun. 30, 2020	$ 8,755,829	5,706,544	(30,146,453)	$ 20,150,116	4,466,036
Balance (in shares) at Jun. 30, 2020	87,558,296,598			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 1,755,255	(1,755,255)			0
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	17,552,551,418
Stock-based compensation expense		1,875			1,875
Net loss			(1,300,965)		(1,300,965)
Balance at Sep. 30, 2020	$ 10,511,084	$ 3,953,164	$ (31,447,418)	$ 20,150,116	$ 3,166,946
Balance (in shares) at Sep. 30, 2020	105,110,848,016			20,150

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
OPERATING ACTIVITIES
Net loss	$ (2,810,939)	$ (3,167,146)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	0	(3,002)
Depreciation and amortization	424,020	449,071
Loss on disposal of assets	0	25,427
Loss on investment	13,714	57,514
Amortization of right-of-use asset	428,740	459,760
Stock-based compensation expense	76,154	343,824
Impairment of intangible assets	380,646	0
Changes in operating assets and liabilities:
Accounts receivable	(20,126)	12,582
Inventories	(28,947)	(16,606)
Prepaid expenses and vendor deposits	(58,175)	94,110
Contract assets	0	14,400
Other assets	57,270	(3,423)
Accounts payable	267,220	(155,910)
Accrued expenses	(2,249)	(294,211)
Contract liabilities	(7,423)	(268,302)
Lease liability	(373,184)	(402,857)
NET CASH USED IN OPERATING ACTIVITIES	(1,653,279)	(2,854,769)
INVESTING ACTIVITIES
Collection of note receivable	23,767	137,250
Purchases of property and equipment	(24,663)	(12,967)
Purchases of patent	(89,415)	(25,000)
NET CASH USED IN INVESTING ACTIVITIES	(90,311)	99,283
FINANCING ACTIVITIES
Proceeds from line of credit	0	131,540
Principal payments on loan payable	(209,941)	(188,323)
Proceeds from paycheck protection program loan	876,515	0
Proceeds from loan and security agreement	2,540,000	0
NET CASH USED IN FINANCING ACTIVITIES	3,206,574	(56,783)
NET DECREASE IN CASH, CASH EQUIVALENT AND RESTRICTED CASH	1,462,984	(2,812,269)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - BEGINNING OF PERIOD	3,525,415	7,061,253
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - END OF PERIOD	4,988,399	4,248,984
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	$ 161,876	$ 107,646

ORGANIZATION

ORGANIZATION	9 Months Ended
	Sep. 30, 2020
ORGANIZATION [Abstract]
ORGANIZATION	Note 1. ORGANIZATION Organization Healthier Choices Management Corp. (c ) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The Company currently operates nine retail vape stores in the Southeast region of the United States, through which it offers e-liquids, vaporizers and related products. The Company also operates Ada’s Natural Market, a natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc and Paradise Health and Nutrition, stores that offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items through its wholly owned subsidiary Healthy Choice Markets 2, LLC. The Company also sells vitamins and supplements on the Amazon.com marketplace through its wholly owned subsidiary Healthy U Wholesale, Inc. The Company markets the Q-Cup™ technology under the vape segment; this patented technology is based on a small, quartz cup called the Q-Cup™, which a customer partially fills with either cannabis or CBD concentrate (approximately 50 mg) purchased from a third party. The Q-Cup™ is then inserted into the Q-Cup™ Tank or Globe, that heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally. COVID-19 Management Update In March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus has recently been recognized as a pandemic by the World Health Organization, and the outbreak has become increasingly widespread in the United States, including in the markets in which the Company operates. The COVID-19 outbreak has had a notable impact on general economic conditions, including but not limited to the temporary closures of many businesses, “shelter in place” and other governmental regulations, reduced consumer spending due to both job losses and other effects attributable to the COVID-19, and there are many unknowns. The Company has adjusted certain aspects of the operations to protect their employees and customers while still meeting customers’ needs. While to date the Company has not been required to close any of its stores, the Company is currently operating under regular hours and we are expecting COVID-19 to have a long-term beneficial impact to the future financial results of the grocery segment. The Company continues to monitor the impact of the COVID-19 outbreak closely. The extent to which the COVID-19 outbreak will impact our operations is manageable, and there is no imminent risk on business continuity and future operation.

GOING CONCERN AND LIQUIDITY

GOING CONCERN AND LIQUIDITY	9 Months Ended
	Sep. 30, 2020
GOING CONCERN AND LIQUIDITY [Abstract]
GOING CONCERN AND LIQUIDITY	Note 2. GOING CONCERN AND LIQUIDITY The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The Company incurred a loss from operations of approximately $2.7 million for the nine months ended September 30, 2020 . As of September 30, 2020 , cash and cash equivalents totaled approximately $0.6 million. equivalents to be generated from operations will not be sufficient to cover our projected operating expenses for the foreseeable future. Management believes these conditions raises substantial doubt about the Company's ability to continue as a going concern within a year and a day from the issuance of these consolidated financial statements. The ability of the Company to continue as a going concern is dependent on the Company's ability to generate significant revenue and raise additional funds (either through equity or debt financings, collaborative agreements or from other sources). There are no assurances that the Company will be successful in its efforts to generate significant revenues, maintain a sufficient cash balance or report profitable operations to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Reclassification Certain amounts in the consolidated financial statements and related notes have been reclassified to conform to the current year presentation. Such reclassifications do not impact the Company's previously reported financial position or net income (loss). Use of Estimates in the Preparation of the Financial Statements The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary. Basis of Presentation and Principles of Consolidation The Company’s unaudited condensed consolidated financial statements are prepared in accordance with GAAP. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), The Vitamin Store, LLC, Healthy U Wholesale, Inc., The Vape Store, Inc. (“Vape Store”), Vaporin, Inc. (“Vaporin”), Smoke Anywhere U.S.A., Inc. (“Smoke”), Emagine the Vape Store, LLC (“Emagine”), IVGI Acquisition, Inc., Vapormax Franchising LLC, Vaporin LLC, and Vaporin Florida, Inc. All intercompany accounts and transactions have been eliminated in consolidation. Recently Adopted Accounting Pronouncements The Company adopted Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). The amendment requires that the statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The Company adopted ASU 2016-18 in the second quarter of 2020 using the retrospective transition method to each period presented. The adoption primarily resulted in the inclusion of the restricted cash balances within the overall cash balances and a reconciliation of cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheet. The adoption of this standard did not have a material impact on the condensed consolidated financial statements and is not expected to have a material impact for the foreseeable future. See “Cash and Cash Equivalents and Restricted Cash” above for further discussion of the effects of the adoption of ASU 2016-18 on the Company’s significant accounting policies. Unaudited Interim Financial Information The unaudited condensed consolidated financial statements have been prepared by the Company and reflect all normal, recurring adjustments that, in the opinion of management, are necessary for a fair presentation of the interim financial information. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for any subsequent quarter or for the year ending December 31, 2020. Certain information and footnotes normally included in financial statements prepared in accordance with GAAP have been omitted under the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the audited consolidated financial statements and related notes thereto as of and for the year ended December 31, 2019

CONCENTRATIONS

CONCENTRATIONS	9 Months Ended
	Sep. 30, 2020
CONCENTRATIONS [Abstract]
CONCENTRATIONS	Note 4. CONCENTRATIONS Cash and Cash Equivalents and Restricted Cash The following table provides a reconciliation of cash, cash equivalents and restricted cash to amounts shown in the statement of cash flows: September 30, 2020 December 31, 2019 Cash and Cash Equivalent $ 602,318 $ 1,525,415 Restricted cash, non-current portion 4,386,081 2,000,000 Total cash, cash equivalents and restricted cash $ 4,988,399 $ 3,525,415 Restricted Cash The Company's restricted cash consists of cash balances which are restricted as to withdrawal or usage under the August 2020 Loan and Security agreement and cash balances obligated to maintain in a money market account as per the April 2018 revolving credit line agreement. See Note 8 for further discussions.

DISAGGREGATION OF REVENUES

DISAGGREGATION OF REVENUES	9 Months Ended
	Sep. 30, 2020
DISAGGREGATION OF REVENUES [Abstract]
DISAGGREGATION OF REVENUES	Note 5. DISAGGREGATION OF REVENUES The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Vapor $ 594,145 $ 898,229 $ 1,888,480 $ 3,207,530 Grocery 2,753,648 2,520,101 8,804,397 8,407,919 Total revenue $ 3,347,793 $ 3,418,330 $ 10,692,877 $ 11,615,449 Retail Vapor $ 594,145 $ 898,216 $ 1,888,480 $ 3,207,120 Retail Grocery 2,369,942 2,168,645 7,707,101 7,302,378 Food service/restaurant 248,757 291,435 823,724 949,211 Online/eCommerce 75,009 45,927 261,158 127,129 Wholesale Grocery 59,940 14,094 12,414 29,201 Wholesale Vapor - 13 - 410 Total revenue $ 3,347,793 $ 3,418,330 $ 10,692,877 $ 11,615,449

INTANGIBLE ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2020
INTANGIBLE ASSETS [Abstract]
INTANGIBLE ASSETS	Note 6. INTANGIBLE ASSETS The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset’s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-35-23, “Impairment or Disposal of Long-Lived Assets.” ASC 360-10-35-23 As part of management's qualitative analysis at September 30, 2020 to determine whether any triggering events have occurred since the last impairment test in December 30, 2019, which would indicate an impairment. Management determined that triggering events had occurred through the nine month ended September 30, 2020 and recorded an impairment to intangible assets. The Company determined that the carrying value of intangible assets for the Vitamin Store are not recoverable based on the monthly average sales for the nine months ended September 30, 2020. The Company concluded that the intangible assets was impaired and recorded an impairment charges of $ 0.4 no Intangible assets, net are as follows: September 30, 2020 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade names 8 10 $ 923,000 $ (418,068) $ 504,932 Customer relationships 4 10 883,000 (420,635) 462,365 Patents 10 359,665 (76,650) 283,015 Non-compete 4 174,000 (77,938) 96,062 Intangible assets, net $ 2,339,665 $ (993,291) $ 1,346,374 December 31, 2019 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade names 8 10 $ 993,000 (354,203) $ 638,797 Customer relationships 4 10 1,228,000 (293,260) 934,740 Patents 10 270,250 (49,027) 221,223 Non-compete 4 174,000 (45,313) 128,687 Intangible assets, net $ 2,665,250 $ (741,803) $ 1,923,447 Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense amounted to approximately $0.3 $0.3 nine months ended September 30, 2020 2019 Years ending December 31, 2020 (remaining three months) $ 98,023 2021 385,091 2022 369,706 2023 130,841 2024 130,841 Thereafter 231,872 Total $ 1,346,374

CONTRACT LIABILITIES

CONTRACT LIABILITIES	9 Months Ended
	Sep. 30, 2020
CONTRACT LIABILITIES [Abstract]
CONTRACT LIABILITIES	Note 7. CONTRACT LIABILITIES The Company’s contract liabilities consists of gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products when customers redeem balances or terms expire through breakage. Our breakage policy is twenty four-month twelve months six months twenty four-month A summary of the net changes in contract liabilities activity for the nine months ended September 30, 2020 2019 As of September 30, 2020 2019 Beginning balance as January 1, $ 26,823 $ 442,630 Issued 33,221 50,778 Redeemed (39,405) (57,319) Breakage recognized (341) (1,563) Fulfillment of contract (898) (260,198) Ending balance as of September 30 $ 19,400 $ 174,328

DEBT

DEBT	9 Months Ended
	Sep. 30, 2020
DEBT [Abstract]
DEBT	Note 8. DEBT The following table provides a breakdown of the Company's debt as of September 30, 2020 Principal Debt Discount Net Amount Line of Credit $ 2,000,000 $ - $ 2,000,000 Term Loan Credit Agreement 870,925 - 870,925 Paycheck Protection Program 880,051 - 880,051 Loan and Security Agreement ("PPE Loan") 2,667,000 (66,322) 2,600,678 Other debt 6,487 - 6,487 Total debt $ 6,424,463 $ (66,322) $ 6,358,141 Line of Credit On April 13, 2018, the Company agreed to a new revolving credit line of $ 2 2 September 30, 2020 one 1.5% 2 September 30, 2020 2 Term Loan Credit Agreement On December 31, 2018, the Company entered into a Term Loan Credit Agreement (the “Credit Agreement”) with Professional Bank, a Florida banking corporation (the “Bank”), pursuant to which the Company issued a Term Note (the “Term Note”) in the principal amount of $ 1,400,000 1.5 5.50% The Credit Agreement contains a customary financial covenant for a minimum debt service coverage ratio of 1.25 December 31, 2023 monthly 22,333 The obligations under the Credit Agreement and the Term Note are guaranteed by the Company and its wholly owned subsidiary, Healthy U Wholesale, Inc. Paycheck Protection Program On May 15, 2020, the Company was granted a loan (the “Loan”) from Customers Bank, in the aggregate amount of $876,515 , pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The Loan, which was in the form of a Note dated May 6, 2020 issued by the Company, matures on May 6, 2022 and bears interest at a rate of 1% per annum, payable monthly commencing on November 6, 2020. The Note may be prepaid by the Borrower at any time prior to maturity with no prepayment penalties. Funds from the Loan may only be used for payroll costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations incurred after May 6, 2020. The Company intends to use the entire Loan amount for these qualifying expenses. Under the terms of the PPP, certain amounts of the Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. Loan and Security Agreement On August 18, 2020, the Company agreed to a loan and security agreement (the “Loan”) in the aggregate of $ 2.7 5% November 16, 2020 20%

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Sep. 30, 2020
STOCKHOLDERS' EQUITY [Abstract]
STOCKHOLDERS' EQUITY	Note 9. STOCKHOLDERS’ EQUITY Series A Warrants In the nine months ended September 30, 2020 37.4 On July 27, 2020 355,661 Series C Stock On September 25, 2020 20,150.1153 $1,000 $0.0001 As of the end of the third quarter of 2020, the closing of the stock exchange had not occurred. Stock Options A summary of Stock-based compensation expense recognized is presented below: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Stock-based compensation $ 1,875 $ 147,570 $ 76,154 $ 343,824 Income (Loss) Per Share The following table summarizes the Company’s securities, in common share equivalents, that have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive: As of September 30, 2020 2019 Preferred stock 201,501,000,000 201,501,000,000 Stock options 68,062,000,000 91,062,000,000 Warrants - 41,420,000,000 Total 269,563,000,000 333,983,000,000

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2020
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 10. COMMITMENTS AND CONTINGENCIES Legal Proceedings Two $0.4 As of September 30, 2020 2020 With respect to legal costs, we record such costs as incurred.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 11. SUBSEQUENT EVENTS The Company evaluated subsequent events through November 18, 2020 September 30, 2020 Series C Stock On November 17, 2020 20,150.1153 $1,000 $0.0001 Term Loan and Security Agreement Extension On November 10, 2020 5%

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Reclassification	Reclassification Certain amounts in the consolidated financial statements and related notes have been reclassified to conform to the current year presentation. Such reclassifications do not impact the Company's previously reported financial position or net income (loss).
Use of Estimates in the Preparation of the Financial Statements	Use of Estimates in the Preparation of the Financial Statements The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.
Basis of Presentation	The Company’s unaudited condensed consolidated financial statements are prepared in accordance with GAAP. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date.
Principles of Consolidation	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), The Vitamin Store, LLC, Healthy U Wholesale, Inc., The Vape Store, Inc. (“Vape Store”), Vaporin, Inc. (“Vaporin”), Smoke Anywhere U.S.A., Inc. (“Smoke”), Emagine the Vape Store, LLC (“Emagine”), IVGI Acquisition, Inc., Vapormax Franchising LLC, Vaporin LLC, and Vaporin Florida, Inc. All intercompany accounts and transactions have been eliminated in consolidation.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements The Company adopted Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). The amendment requires that the statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The Company adopted ASU 2016-18 in the second quarter of 2020 using the retrospective transition method to each period presented. The adoption primarily resulted in the inclusion of the restricted cash balances within the overall cash balances and a reconciliation of cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheet. The adoption of this standard did not have a material impact on the condensed consolidated financial statements and is not expected to have a material impact for the foreseeable future. See “Cash and Cash Equivalents and Restricted Cash” above for further discussion of the effects of the adoption of ASU 2016-18 on the Company’s significant accounting policies.

CONCENTRATIONS (Tables)

CONCENTRATIONS (Tables)	9 Months Ended
	Sep. 30, 2020
CONCENTRATIONS [Abstract]
Cash, Cash Equivalents and Restricted Cash	The following table provides a reconciliation of cash, cash equivalents and restricted cash to amounts shown in the statement of cash flows: September 30, 2020 December 31, 2019 Cash and Cash Equivalent $ 602,318 $ 1,525,415 Restricted cash, non-current portion 4,386,081 2,000,000 Total cash, cash equivalents and restricted cash $ 4,988,399 $ 3,525,415

DISAGGREGATION OF REVENUES (Tab

DISAGGREGATION OF REVENUES (Tables)	9 Months Ended
	Sep. 30, 2020
DISAGGREGATION OF REVENUES [Abstract]
Disaggregated Revenue	The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Vapor $ 594,145 $ 898,229 $ 1,888,480 $ 3,207,530 Grocery 2,753,648 2,520,101 8,804,397 8,407,919 Total revenue $ 3,347,793 $ 3,418,330 $ 10,692,877 $ 11,615,449 Retail Vapor $ 594,145 $ 898,216 $ 1,888,480 $ 3,207,120 Retail Grocery 2,369,942 2,168,645 7,707,101 7,302,378 Food service/restaurant 248,757 291,435 823,724 949,211 Online/eCommerce 75,009 45,927 261,158 127,129 Wholesale Grocery 59,940 14,094 12,414 29,201 Wholesale Vapor - 13 - 410 Total revenue $ 3,347,793 $ 3,418,330 $ 10,692,877 $ 11,615,449

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2020
INTANGIBLE ASSETS [Abstract]
Intangible Assets, Net	Intangible assets, net are as follows: September 30, 2020 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade names 8 10 $ 923,000 $ (418,068) $ 504,932 Customer relationships 4 10 883,000 (420,635) 462,365 Patents 10 359,665 (76,650) 283,015 Non-compete 4 174,000 (77,938) 96,062 Intangible assets, net $ 2,339,665 $ (993,291) $ 1,346,374 December 31, 2019 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade names 8 10 $ 993,000 (354,203) $ 638,797 Customer relationships 4 10 1,228,000 (293,260) 934,740 Patents 10 270,250 (49,027) 221,223 Non-compete 4 174,000 (45,313) 128,687 Intangible assets, net $ 2,665,250 $ (741,803) $ 1,923,447
Future Annual Estimated Amortization Expense	Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense amounted to approximately $0.3 $0.3 nine months ended September 30, 2020 2019 Years ending December 31, 2020 (remaining three months) $ 98,023 2021 385,091 2022 369,706 2023 130,841 2024 130,841 Thereafter 231,872 Total $ 1,346,374

CONTRACT LIABILITIES (Tables)

CONTRACT LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2020
CONTRACT LIABILITIES [Abstract]
Summary of Net Changes in Contract Liabilities	A summary of the net changes in contract liabilities activity for the nine months ended September 30, 2020 2019 As of September 30, 2020 2019 Beginning balance as January 1, $ 26,823 $ 442,630 Issued 33,221 50,778 Redeemed (39,405) (57,319) Breakage recognized (341) (1,563) Fulfillment of contract (898) (260,198) Ending balance as of September 30 $ 19,400 $ 174,328

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Sep. 30, 2020
DEBT [Abstract]
Breakdown of Debt	Note 8. DEBT The following table provides a breakdown of the Company's debt as of September 30, 2020 Principal Debt Discount Net Amount Line of Credit $ 2,000,000 $ - $ 2,000,000 Term Loan Credit Agreement 870,925 - 870,925 Paycheck Protection Program 880,051 - 880,051 Loan and Security Agreement ("PPE Loan") 2,667,000 (66,322) 2,600,678 Other debt 6,487 - 6,487 Total debt $ 6,424,463 $ (66,322) $ 6,358,141

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	9 Months Ended
	Sep. 30, 2020
STOCKHOLDERS' EQUITY [Abstract]
Compensation Expense Recognized	A summary of Stock-based compensation expense recognized is presented below: Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Stock-based compensation $ 1,875 $ 147,570 $ 76,154 $ 343,824
Common Share Equivalent Excluded from Calculation of Dilutive Loss Per Share	The following table summarizes the Company’s securities, in common share equivalents, that have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive: As of September 30, 2020 2019 Preferred stock 201,501,000,000 201,501,000,000 Stock options 68,062,000,000 91,062,000,000 Warrants - 41,420,000,000 Total 269,563,000,000 333,983,000,000

ORGANIZATION (Details)

ORGANIZATION (Details)	Sep. 30, 2020Store
ORGANIZATION [Abstract]
Number of operating retail vape stores	9

GOING CONCERN AND LIQUIDITY (De

GOING CONCERN AND LIQUIDITY (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
GOING CONCERN AND LIQUIDITY [Abstract]
Loss from operations	$ (1,213,802)	$ (1,129,363)	$ (2,673,156)	$ (3,089,125)
Cash and cash equivalents	602,318		602,318		$ 1,525,415
Restricted cash	$ 4,386,081		$ 4,386,081		$ 2,000,000

CONCENTRATIONS (Details)

CONCENTRATIONS (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Cash, Cash Equivalents and Restricted Cash [Abstract]
Cash and Cash Equivalent	$ 602,318	$ 1,525,415
Restricted cash, non-current portion	4,386,081	2,000,000
Total cash, cash equivalents and restricted cash	$ 4,988,399	$ 3,525,415	$ 4,248,984	$ 7,061,253

DISAGGREGATION OF REVENUES (Det

DISAGGREGATION OF REVENUES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Abstract]
Revenue	$ 3,347,793	$ 3,418,330	$ 10,692,877	$ 11,615,449
Vapor [Member]
Disaggregation of Revenue [Abstract]
Revenue	594,145	898,229	1,888,480	3,207,530
Grocery [Member]
Disaggregation of Revenue [Abstract]
Revenue	2,753,648	2,520,101	8,804,397	8,407,919
Retail Vapor [Member]
Disaggregation of Revenue [Abstract]
Revenue	594,145	898,216	1,888,480	3,207,120
Retail Grocery [Member]
Disaggregation of Revenue [Abstract]
Revenue	2,369,942	2,168,645	7,707,101	7,302,378
Food Service/Restaurant [Member]
Disaggregation of Revenue [Abstract]
Revenue	248,757	291,435	823,724	949,211
Online/eCommerce [Member]
Disaggregation of Revenue [Abstract]
Revenue	75,009	45,927	261,158	127,129
Wholesale Grocery [Member]
Disaggregation of Revenue [Abstract]
Revenue	59,940	14,094	12,414	29,201
Wholesale Vapor [Member]
Disaggregation of Revenue [Abstract]
Revenue	$ 0	$ 13	$ 0	$ 410

INTANGIBLE ASSETS, Intangible A

INTANGIBLE ASSETS, Intangible Assets, Net (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Intangible Assets, Net [Abstract]
Impairment of intangible assets	$ 380,646	$ 0	$ 380,646	$ 0
Gross carrying amount	2,339,665		2,339,665		$ 2,665,250
Accumulated amortization	(993,291)		(993,291)		(741,803)
Net carrying amount	1,346,374		1,346,374		1,923,447
Trade Names [Member]
Intangible Assets, Net [Abstract]
Gross carrying amount	923,000		923,000		993,000
Accumulated amortization	(418,068)		(418,068)		(354,203)
Net carrying amount	504,932		$ 504,932		$ 638,797
Trade Names [Member] | Minimum [Member]
Intangible Assets, Net [Abstract]
Useful lives			8 years		8 years
Trade Names [Member] | Maximum [Member]
Intangible Assets, Net [Abstract]
Useful lives			10 years		10 years
Customer Relationships [Member]
Intangible Assets, Net [Abstract]
Gross carrying amount	883,000		$ 883,000		$ 1,228,000
Accumulated amortization	(420,635)		(420,635)		(293,260)
Net carrying amount	462,365		$ 462,365		$ 934,740
Customer Relationships [Member] | Minimum [Member]
Intangible Assets, Net [Abstract]
Useful lives			4 years		4 years
Customer Relationships [Member] | Maximum [Member]
Intangible Assets, Net [Abstract]
Useful lives			10 years		10 years
Patents [Member]
Intangible Assets, Net [Abstract]
Useful lives			10 years		10 years
Gross carrying amount	359,665		$ 359,665		$ 270,250
Accumulated amortization	(76,650)		(76,650)		(49,027)
Net carrying amount	283,015		$ 283,015		$ 221,223
Non-compete [Member]
Intangible Assets, Net [Abstract]
Useful lives			4 years		4 years
Gross carrying amount	174,000		$ 174,000		$ 174,000
Accumulated amortization	(77,938)		(77,938)		(45,313)
Net carrying amount	$ 96,062		$ 96,062		$ 128,687

INTANGIBLE ASSETS, Future Annua

INTANGIBLE ASSETS, Future Annual Estimated Amortization Expense (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
INTANGIBLE ASSETS [Abstract]
Amortization expense	$ 300,000	$ 300,000
Future Annual Estimated Amortization Expense [Abstract]
2020 (remaining three months)	98,023
2021	385,091
2022	369,706
2023	130,841
2024	130,841
Thereafter	231,872
Net carrying amount	$ 1,346,374		$ 1,923,447

CONTRACT LIABILITIES (Details)

CONTRACT LIABILITIES (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Deferred Revenue [Abstract]
Period by which contract liabilities are expected to be recognized	24 months
Changes in Contract Liabilities Activity [Roll Forward]
Beginning balance as January 1,	$ 26,823	$ 442,630
Issued	33,221	50,778
Redeemed	(39,405)	(57,319)
Breakage recognized	(341)	(1,563)
Fulfillment of contract	(898)	(260,198)
Ending balance as of June 30,	$ 19,400	$ 174,328
Gift Cards [Member]
Deferred Revenue [Abstract]
Breakage policy period	24 months
Grocery Loyalty Rewards [Member]
Deferred Revenue [Abstract]
Breakage policy period	12 months
Vapor Loyalty Rewards [Member]
Deferred Revenue [Abstract]
Breakage policy period	6 months

DEBT (Details)

DEBT (Details) - USD ($)	Aug. 18, 2020	Sep. 30, 2020	Dec. 31, 2018	May 15, 2020
Debt [Abstract]
Principal		$ 6,424,463
Debt Discount		(66,322)
Net Amount		6,358,141
Line of Credit [Abstract]
Collateral arrangement amount		2,000,000
Term Loan Credit Agreement [Member]
Debt [Abstract]
Principal		870,925
Debt Discount		0
Net Amount		$ 870,925
Line of Credit [Abstract]
Face amount			$ 1,400,000
Debt instrument interest rate			5.50%
Term Loan and Security Agreement		Dec. 31, 2023
Monthly principle payments			$ 22,333
Frequency of payment		monthly
Term Loan Credit Agreement [Member] | Minimum [Member]
Line of Credit [Abstract]
Debt service coverage ratio			1.25
Term Loan Credit Agreement [Member] | Prime Rate [Member]
Line of Credit [Abstract]
Basis adjustment to variable rate			1.50%
Paycheck Protection Program [Member]
Debt [Abstract]
Principal		$ 880,051
Debt Discount		0
Net Amount		$ 880,051
Line of Credit [Abstract]
Face amount				$ 876,515
Term Loan and Security Agreement		May 6, 2022
Non-refundable discount percentage				1.00%
Frequency of payment		monthly
Loan and Security Agreement ("PPE Loan") [Member]
Debt [Abstract]
Principal		$ 2,667,000
Debt Discount		(66,322)
Net Amount		$ 2,600,678
Line of Credit [Abstract]
Face amount	$ 2,700,000
Non-refundable discount percentage	5.00%
Term Loan and Security Agreement		Nov. 16, 2020
Percentage of net profits received from sales of PPE	20.00%
Other Debt [Member]
Debt [Abstract]
Principal		$ 6,487
Debt Discount		0
Net Amount		6,487
Revolving Credit Line [Member]
Line of Credit [Abstract]
Revolving credit line		2,000,000
Money market amount		$ 2,000,000
Renewal period		1 year
Basis adjustment to variable rate		1.50%
Line of Credit [Member]
Debt [Abstract]
Principal		$ 2,000,000
Debt Discount		0
Net Amount		$ 2,000,000

STOCKHOLDERS' EQUITY, Series A

STOCKHOLDERS' EQUITY, Series A Warrants & Series C Stock (Details) - $ / shares	Sep. 25, 2020	Sep. 30, 2020	Jul. 27, 2020	Dec. 31, 2019
STOCKHOLDERS' EQUITY [Abstract]
Issuance of common stock in connection with cashless exercise of Series A warrants		37,412,353,771
Series A warrants expired (in shares)			355,661
Series C Preferred Stock [Abstract]
Preferred stock stated value (in dollars per share)		$ 1,000		$ 1,000
Series C Stock [Member]
Series C Preferred Stock [Abstract]
Number of stock exchanged for in the transaction (in shares)	20,150.1153
Preferred stock stated value (in dollars per share)	$ 1,000
Conversion price (in dollars per share)	$ 0.0001

STOCKHOLDERS' EQUITY, Stock Opt

STOCKHOLDERS' EQUITY, Stock Options (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Compensation Expense Recognized [Abstract]
Stock-based compensation	$ 1,875	$ 147,570	$ 76,154	$ 343,824

STOCKHOLDERS' EQUITY, Income (L

STOCKHOLDERS' EQUITY, Income (Loss) Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]
Antidilutive securities excluded from computation of diluted loss per share (in shares)	269,563,000,000	333,983,000,000
Preferred Stock [Member]
Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]
Antidilutive securities excluded from computation of diluted loss per share (in shares)	201,501,000,000	201,501,000,000
Stock Options [Member]
Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]
Antidilutive securities excluded from computation of diluted loss per share (in shares)	68,062,000,000	91,062,000,000
Warrants [Member]
Common Share Equivalents Excluded from Calculation of Dilutive Loss Per Share [Abstract]
Antidilutive securities excluded from computation of diluted loss per share (in shares)	0	41,420,000,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - Alleged Claimed Battery Defects For Electronic Cigarette Device [Member]	9 Months Ended
	Sep. 30, 2020USD ($)Lawsuit
Legal Proceedings [Abstract]
Number of lawsuits | Lawsuit	2
Medical Costs [Member]
Legal Proceedings [Abstract]
Damages sought | $	$ 400,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - $ / shares	Nov. 17, 2020	Nov. 10, 2020	Sep. 25, 2020	Sep. 30, 2020	Dec. 31, 2019
Series C Preferred Stock [Abstract]
Preferred stock stated value (in dollars per share)				$ 1,000	$ 1,000
Loan and Security Agreement ("PPE Loan") [Member]
Series C Preferred Stock [Abstract]
Term Loan and Security Agreement				Nov. 16, 2020
Series C Stock [Member]
Series C Preferred Stock [Abstract]
Number of stock exchanged for in the transaction (in shares)			20,150.1153
Preferred stock stated value (in dollars per share)			$ 1,000
Conversion price (in dollars per share)			$ 0.0001
Subsequent Event [Member] | Loan and Security Agreement ("PPE Loan") [Member]
Series C Preferred Stock [Abstract]
Term Loan and Security Agreement		Feb. 7, 2020
Non-refundable discount percentage		5.00%
Subsequent Event [Member] | Series C Stock [Member]
Series C Preferred Stock [Abstract]
Number of stock exchanged for in the transaction (in shares)	20,150.1153
Preferred stock stated value (in dollars per share)	$ 1,000
Conversion price (in dollars per share)	$ 0.0001